PLXNA3
Basic information
Region (hg38): X:154458281-154477779
Previous symbols: [ "PLXN4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLXNA3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 153 | 12 | 168 | |||
missense | 161 | 29 | 10 | 200 | ||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 5 | 22 | 2 | 29 | ||
non coding | 8 | |||||
Total | 0 | 0 | 170 | 189 | 23 |
Variants in PLXNA3
This is a list of pathogenic ClinVar variants found in the PLXNA3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-154460177-G-A | PLXNA3-related disorder | Likely benign (Mar 03, 2024) | ||
X-154460179-C-T | PLXNA3-related disorder | Likely benign (Apr 06, 2022) | ||
X-154460180-G-A | PLXNA3-related disorder | Likely benign (May 25, 2022) | ||
X-154460193-G-C | PLXNA3-related disorder | Uncertain significance (May 02, 2024) | ||
X-154460195-C-G | PLXNA3-related disorder | Benign (Dec 03, 2018) | ||
X-154460201-C-T | PLXNA3-related disorder | Likely benign (Mar 13, 2019) | ||
X-154460202-C-T | PLXNA3-related disorder | Uncertain significance (Aug 14, 2024) | ||
X-154460222-C-T | PLXNA3-related disorder | Likely benign (Jun 27, 2022) | ||
X-154460223-G-A | not specified | Uncertain significance (Apr 20, 2023) | ||
X-154460224-T-TG | PLXNA3-related disorder | Uncertain significance (Jan 24, 2024) | ||
X-154460225-G-C | PLXNA3-related disorder | Likely benign (Sep 10, 2021) | ||
X-154460226-G-C | PLXNA3-related disorder | Uncertain significance (Jan 09, 2024) | ||
X-154460228-G-A | PLXNA3-related disorder | Likely benign (Dec 20, 2021) | ||
X-154460231-G-T | PLXNA3-related disorder | Likely benign (Jun 02, 2021) | ||
X-154460238-G-A | PLXNA3-related disorder • not specified | Uncertain significance (Dec 19, 2022) | ||
X-154460239-G-A | Short stature • not specified • PLXNA3-related disorder | Conflicting classifications of pathogenicity (Jul 14, 2022) | ||
X-154460253-C-T | not specified • PLXNA3-related disorder | Uncertain significance (May 20, 2024) | ||
X-154460254-G-A | PLXNA3-related disorder | Benign (Dec 31, 2019) | ||
X-154460261-C-T | PLXNA3-related disorder | Likely benign (Feb 21, 2019) | ||
X-154460262-G-A | PLXNA3-related disorder • not specified | Uncertain significance (Oct 26, 2022) | ||
X-154460278-C-T | not specified • PLXNA3-related disorder | Uncertain significance (Dec 06, 2022) | ||
X-154460288-C-G | PLXNA3-related disorder | Uncertain significance (May 27, 2024) | ||
X-154460301-C-T | PLXNA3-related disorder | Uncertain significance (Mar 14, 2024) | ||
X-154460302-G-A | PLXNA3-related disorder | Uncertain significance (Aug 19, 2024) | ||
X-154460307-A-T | PLXNA3-related disorder | Uncertain significance (Apr 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLXNA3 | protein_coding | protein_coding | ENST00000369682 | 32 | 15369 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0549 | 0.945 | 125706 | 15 | 13 | 125734 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.676 | 853 | 910 | 0.937 | 0.0000874 | 12137 |
Missense in Polyphen | 331 | 425.32 | 0.77823 | 5763 | ||
Synonymous | -4.98 | 538 | 410 | 1.31 | 0.0000411 | 3893 |
Loss of Function | 5.39 | 15 | 60.1 | 0.250 | 0.00000472 | 885 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000269 | 0.000232 |
Ashkenazi Jewish | 0.000134 | 0.0000992 |
East Asian | 0.0000740 | 0.0000544 |
Finnish | 0.0000628 | 0.0000462 |
European (Non-Finnish) | 0.000225 | 0.000149 |
Middle Eastern | 0.0000740 | 0.0000544 |
South Asian | 0.000157 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Coreceptor for SEMA3A and SEMA3F. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance in the developing nervous system. Regulates the migration of sympathetic neurons, but not of neural crest precursors. Required for normal dendrite spine morphology in pyramidal neurons. May play a role in regulating semaphorin-mediated programmed cell death in the developing nervous system. Class 3 semaphorins bind to a complex composed of a neuropilin and a plexin. The plexin modulates the affinity of the complex for specific semaphorins, and its cytoplasmic domain is required for the activation of down-stream signaling events in the cytoplasm.;
- Pathway
- Axon guidance - Homo sapiens (human);Developmental Biology;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Sema3A PAK dependent Axon repulsion;Semaphorin interactions;Axon guidance;CRMPs in Sema3A signaling
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- 0.284
- rvis_EVS
- -2.49
- rvis_percentile_EVS
- 0.94
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- Y
- hipred_score
- 0.659
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.239
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plxna3
- Phenotype
- cellular phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- plxna3
- Affected structure
- primary motor neuron
- Phenotype tag
- abnormal
- Phenotype quality
- spatial pattern
Gene ontology
- Biological process
- negative regulation of cell adhesion;multicellular organism development;regulation of cell shape;facial nerve structural organization;trigeminal nerve structural organization;hippocampus development;branchiomotor neuron axon guidance;pyramidal neuron development;regulation of cell migration;regulation of GTPase activity;negative regulation of axon extension involved in axon guidance;positive regulation of axonogenesis;negative chemotaxis;positive regulation of cytoskeleton organization;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in axon guidance;neuron projection extension
- Cellular component
- semaphorin receptor complex;nucleus;plasma membrane;integral component of plasma membrane;membrane;cell junction;intracellular membrane-bounded organelle
- Molecular function
- transmembrane signaling receptor activity;protein binding;semaphorin receptor activity